"Our vision is to one day make comprehensive blood typing for all donor and patient blood the standard of care.” By enabling more precise blood type research, we can help researchers develop strategies to improve transfusion safety for millions of patients in need of frequent blood donations, such as patients undergoing #cancer treatment or living with #sicklecell disorder, who are at higher risk of experiencing a dangerous transfusion reaction. We are excited to introduce our innovative new solution to help pave the way for a future of safer blood transfusions. https://lnkd.in/eSMs4-sS
Thermo Fisher Scientific
Biotechnology Research
Waltham, MA 1,524,886 followers
The World Leader In Serving Science
About us
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
- Website
-
https://www.thermofisher.com
External link for Thermo Fisher Scientific
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Waltham, MA
- Type
- Public Company
- Specialties
- Analytical Instruments, Laboratory Supply Chain Programs and eCommerce, Laboratory Equipment, Lab Services, Specialty Diagnostics, Life Sciences, Pharma Services, and CDMO
Locations
-
Primary
168 Third Avenue
Waltham, MA, US
Employees at Thermo Fisher Scientific
-
Jane Li
Senior Director, Pharma CDx and CRO Partnership
-
Veronika Galvez,
Category Manager at Thermo Fisher Scientific
-
Steve Marteney
Senior Technology and Software Development Leader
-
Toshiko Banno Hadden
IT Director (RETIRED), Enterprise Technology & Operations Thermo Fisher Scientific
Updates
-
$50.7 million – that’s how much Nevada’s Washoe County saved in 2023 by diverting people with a history of substance misuse or addiction to alternative sentencing programs instead of sending them to jail. Those savings were then spent elsewhere on services aimed at making the local community safer. Washoe County is one of several jurisdictions across the United States that is tackling criminal recidivism by addressing the underlying addiction that causes many repeat offenders to break the law. Frequent and random drug testing enables the County’s Sober 24 testing facility to help people with addiction get clean, while the underlying screening technology provides a customizable solution that can be easily updated based on the probationers’ proclivities and ever-changing illicit drug trends in the communities. Learn more about how Sober 24 is having an impact on people like Chris and Jasmin: https://lnkd.in/ecfd2Q9d
-
Researchers at the University at Buffalo are working to improve the diagnosis and treatment of complex, potentially devastating diseases like Alzheimer’s through protein mapping, or proteomics. Jun Qu, PhD., the group leader of the Proteomics and Bioanalysis lab, has seen improvements in the speed of his research using the Orbitrap Astral Mass Spectrometer. According to Qu, “If we used traditional biochemical technology, it might take decades to test each protein in a project like this. Here, we take a very small sample, and we can quantify 10,000 proteins in seconds.” Read more about how Qu and his team are helping advance the understanding of diseases and ultimately keep the world healthier using our newest equipment:
-
The World Economic Forum just issued a new report that outlines five trends shaping the rewiring of global value chains, informed in part by insights from our team. Learn more about how trends like a digital-first model of operations, greater focus on customer value, and greater emphasis on skills and innovation are impacting global operations. Access the full report: https://lnkd.in/dYbSXerA
Reality Check on value chain changes: Global #value chains are fraught with challenges that are complicated by internal and external headwinds. As global disruptions become more intense and more frequent, safeguarding global value chains is top-of-mind from factory floors to executive boardrooms. The World Economic Forum released a report that highlights the key trends and the significant gap that is emerging between strategic intent and operational delivery. As a core community member of the World Economic Forum’s ‘Future-proofing Global Value Chains: Country Readiness and Beyond initiative’, Thermo Fisher Scientific is delighted to have had the opportunity to support this research and provide our perspective and approach to this ongoing rewiring. Read more here: https://lnkd.in/dTqFbsWh #manufacturing #supplychains
Global value chains
weforum.org
-
For people in need of a kidney transplant, finding a match can take years. Throw in a patient whose immune system has formed antibodies that could increase the risk of rejection, and the matching process can get even more complex. That’s the situation Kadin Hoven and his family found themselves in after Kadin experienced two transplants and two rejections by the time he was just 7 years old. Doctors told Kadin’s parents the chances of finding a third match were incredibly low. So began Kadin’s three-year journey on dialysis – until a family friend stepped up to get tested despite the odds. And thanks to the power of science, Kadin found his perfect match. To learn how you could be a match for one of the more than 100,000 people around the world waiting for a kidney transplant, visit http://spr.ly/6047jof3P
-
Join us at the PEG Summit, the essential industry conference for streamlining biologics development. This conference is designed to bring together leading experts, researchers, and industry professionals for a dynamic and informative gathering. Come find us at PEGS booth #115 for optimized gene synthesis and protein expression products and services.
This content isn’t available here
Access this content and more in the LinkedIn app
-
As demand for batteries continues to grow, there is a need for innovative production methods that maintain quality and increase production yield. In a POWER magazine article, Kyle D'Silva, Director of Clean Energy for Analytical Instruments, shares how our solutions support more efficient battery production – from the mine to the production line. Read the article to learn more:
From Mine to Line through End of Life, How Technology is Optimizing Battery Production
powermag.com
-
Our most recent #ScienceWithATwist episode covered the effects of plastic waste and the importance of localized recycling - but don't miss out on our full season of episodes. You can listen to all of our podcast episodes and hear discussions on a range of topics - from forever chemicals to gene therapies - featuring scientific experts here:
Season Two
corporate.thermofisher.com
-
Congratulations to Dr. Rose Blackburne, MD, MBA, V.P. and Global Head of General Medicine and Women’s Health, on being honored by BlackDoctor.org in the Top Blacks in Healthcare awards. For two decades, Dr. Blackburne has been unwavering in her commitment to reducing disparities in clinical trial research and advancing women’s health. In recognition of her dedication and #WomensHealthMonth, check out her thoughts on The White House initiatives and investments in women’s health research and the vital role and changes that need to prioritize be made in inclusivity in clinical trials:
Perspectives: Response to White House Initiatives on Women's Health Research
corporate.thermofisher.com
Affiliated pages
Similar pages
Browse jobs
Stock
TMO
NYSE
20 minutes delay
$599.02
4.22 (0.71%)
- Open
- 600
- Low
- 595.03
- High
- 602
Data from Refinitiv
See more info on